Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Resource Information

The work Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998 represents a distinct intellectual or artistic creation found in Brigham Young University. This resource is a combination of several types including: Work, Language Material, Books.

The Resource Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Label: Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Title remainder: adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Creator

United States, Congress | House | Committee on Government Reform and Oversight

Subject

Language: eng

Member of

LexisNexis U.S. Congressional Hearings Digital Collection

Cataloging source: UMI

Government publication: federal national government publication

Index: no index present

Literary form: non fiction

Nature of contents

dictionaries
bibliography

Context

Context of Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by Brigham Young University. Additional terms may apply to data associated with third party namespaces.

Link Analysis (Experimental)

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Local Identifier: http://link.lib.byu.edu/resource/Y_LSrzk0m6c/

Network Identifier: http://library.link/resource/Y_LSrzk0m6c/

Resource Description Namespaces

Network Analysis

Inbound Links: 1 1 Total

1 In Library based on 1 Link Type

Outbound Links: 7 4 Total
7 To Library based on 4 Link Types

Shared in Network

This resource is rare in the Library.Link network

Click the 'Analyze Network' button to show other libraries in the Library.Link network that share this resource

Currently shared across 0 libraries and 0 members of Brigham Young University

http://link.lib.byu.edu/

Context

Item

Work of

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Resource Description Namespaces

Network Analysis

Shared in Network

1 Items of the Work Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Context

Item

Work of

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Resource Description Namespaces

Network Analysis

Shared in Network Analyze Network

Shared in Network